niacinamide has been researched along with Pulmonary Disease, Chronic Obstructive in 6 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic obstructive pulmonary disease (COPD) is a common, progressive respiratory disease that causes great morbidity and mortality despite treatment." | 2.71 | The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients. ( Belleguic, C; Bertrand, C; Brinchault, G; Depincé, A; Lagente, V; Leportier-Comoy, C; Martin-Chouly, CA; Ouagued, M; Pruniaux, MP, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, B | 1 |
| San José Estépar, R | 2 |
| Godbole, S | 1 |
| Curtis, JL | 1 |
| Wang, JM | 1 |
| Rosas, IO | 1 |
| Mayers, JR | 1 |
| Hobbs, BD | 1 |
| Hersh, CP | 1 |
| Ash, SY | 1 |
| Han, MK | 1 |
| Bowler, RP | 1 |
| Stringer, KA | 1 |
| Washko, GR | 1 |
| Labaki, WW | 1 |
| De Savi, C | 1 |
| Cox, RJ | 1 |
| Warner, DJ | 1 |
| Cook, AR | 1 |
| Dickinson, MR | 1 |
| McDonough, A | 1 |
| Morrill, LC | 1 |
| Parker, B | 1 |
| Andrews, G | 1 |
| Young, SS | 1 |
| Gilmour, PS | 1 |
| Riley, R | 1 |
| Dearman, MS | 1 |
| Xie, J | 1 |
| Poda, GI | 1 |
| Hu, Y | 1 |
| Chen, NX | 1 |
| Heier, RF | 1 |
| Wolfson, SG | 1 |
| Reding, MT | 1 |
| Lennon, PJ | 1 |
| Kurumbail, RG | 1 |
| Selness, SR | 1 |
| Li, X | 1 |
| Kishore, NN | 1 |
| Sommers, CD | 1 |
| Christine, L | 1 |
| Bonar, SL | 1 |
| Venkatraman, N | 1 |
| Mathialagan, S | 1 |
| Brustkern, SJ | 1 |
| Huang, HC | 1 |
| Thurairatnam, S | 1 |
| Ouagued, M | 1 |
| Martin-Chouly, CA | 1 |
| Brinchault, G | 1 |
| Leportier-Comoy, C | 1 |
| Depincé, A | 1 |
| Bertrand, C | 1 |
| Lagente, V | 1 |
| Belleguic, C | 1 |
| Pruniaux, MP | 1 |
| Newton, R | 1 |
| Holden, NS | 1 |
| Catley, MC | 1 |
| Oyelusi, W | 1 |
| Leigh, R | 1 |
| Proud, D | 1 |
| Barnes, PJ | 1 |
1 review available for niacinamide and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Hematopoietic prostaglandin D synthase inhibitors.
Topics: Alzheimer Disease; Animals; Asthma; Dermatitis, Atopic; Drug Design; Enzyme Inhibitors; Humans; Intr | 2012 |
1 trial available for niacinamide and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Azepines; Carboxylic Acids; Cyclic Nucleotide Phosphodie | 2005 |
4 other studies available for niacinamide and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers.
Topics: Emphysema; Humans; Lung; Niacin; Niacinamide; Pulmonary Disease, Chronic Obstructive; Pulmonary Emph | 2023 |
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Benzamides; Dogs; Ferrets; Humans; Li | 2014 |
Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure-activity relationship.
Topics: Administration, Inhalation; Aminopyridines; Asthma; Binding, Competitive; Drug Design; HEK293 Cells; | 2011 |
Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Topics: Carbolines; Cells, Cultured; Cytokines; Epithelial Cells; Gene Expression Regulation; Heterocyclic C | 2007 |